Richard Aplenc

Richard Aplenc

Children's Hospital of Philadelphia - Philadelphia / United States
Others
AD Scientific Index ID: 4687813
person_outline Richard Aplenc's MOST POPULAR ARTICLES
1-) Chimeric antigen receptor T cells for sustained remissions in leukemiaSL Maude, N Frey, PA Shaw, R Aplenc, DM Barrett, NJ Bunin, A Chew, ...New England Journal of Medicine 371 (16), 1507-1517, 201449092014
2-) Chimeric antigen receptor–modified T cells for acute lymphoid leukemiaSA Grupp, M Kalos, D Barrett, R Aplenc, DL Porter, SR Rheingold, ...New England Journal of Medicine 368 (16), 1509-1518, 201336132013
3-) Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemiaDT Teachey, SF Lacey, PA Shaw, JJ Melenhorst, SL Maude, N Frey, ...Cancer discovery 6 (6), 664-679, 20167842016
4-) Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapyDT Teachey, SR Rheingold, SL Maude, G Zugmaier, DM Barrett, AE Seif, ...Blood, The Journal of the American Society of Hematology 121 (26), 5154-5157, 20137022013
5-) Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase …AS Gamis, TA Alonzo, S Meshinchi, L Sung, RB Gerbing, SC Raimondi, ...Journal of Clinical Oncology 32 (27), 3021-3032, 20144752014